Results 221 to 230 of about 92,115 (273)

Watch-and-Wait strategy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy: a comprehensive review. [PDF]

Front Oncol
Huang P, Zhao X, Fei H, Zhang L, Liu X, Yu Y, Wu R, Fei F.   +7 more
europepmc   +1 more source

Pathological tumor response and its association with recurrence patterns and survival after neoadjuvant chemoradiotherapy and esophagectomy for esophageal squamous cell carcinoma: a tertiary care center experience from India. [PDF]

Korean J Clin Oncol
Khan F, Surendran S, Samarasam I, Yacob M, Paul N, Rani J, Isiah R, Pavamani S, Sasidharan BK, Mathew M.   +9 more
europepmc   +1 more source

Multiparametric MRI-derived biomarkers for preoperative prediction of recurrence and/or metastasis after neoadjuvant chemoradiotherapy in locally advanced rectal cancer. [PDF]

Quant Imaging Med Surg
Ye Q, Han D, Hou J, Huang Y, Chen N, Ao W, Mao G.   +6 more
europepmc   +1 more source

Predictive value of primary gross tumor volume measured by MRI in response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. [PDF]

J Appl Clin Med Phys
Li J, Wu Y, Ye S, Fan C, Lin Y, Yang D, Xia X, Kang Y, Liu D, Wu J.   +9 more
europepmc   +1 more source

Efficacy and safety of neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in locally advanced resectable esophageal squamous cell carcinoma. [PDF]

J Cancer Res Clin Oncol
Jiang Y, Wu Z, Wang W, Yu J, Gao A.
europepmc   +1 more source

A 13-gene prognostic model developed using machine learning to predict the response to neoadjuvant chemoradiotherapy in rectal carcinoma. [PDF]

Cancer Cell Int
Gao Z, Qiu M, Yang Z, Fang X, Yin G, Zhang Q, Liu J, Liu R, Wang Y, Liu Y, Zhang M, Zhang H, Zheng X, Wang H, Hao J, Gao M.   +15 more
europepmc   +1 more source

Efficacy and safety of neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced esophagogastric junction or gastric cancer: a systematic review and meta analysis. [PDF]

Front Immunol
Ma X, Guo W, Sun J, Liang Y, Yao C, Chi Y, Chi Z, Li T, Wang R, Gao R, Gao Y, Zhang Z, Miao M, Shang K, Gao C.   +14 more
europepmc   +1 more source

Hemophagocytic syndrome caused by Epstein-Barr virus and cytomegalovirus infection during neoadjuvant chemoradiotherapy for rectal cancer: a case report. [PDF]

Front Med (Lausanne)
Kanesada K, Yoshimatsu K, Yano S, Higashida M, Okada T, Endo S, Fujiwara Y, Ueno T.   +7 more
europepmc   +1 more source

A meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally resectable esophageal cancer based on RCTs. [PDF]

Front Oncol
Xu T, Wang L, Zhang X, Yu X, Zhang S, Zheng J, Fei J.   +6 more
europepmc   +1 more source

Neoadjuvant chemoradiotherapy for esophageal carcinoma

Diseases of the Esophagus, 2005
SUMMARY. Neoadjuvant chemoradiotherapy is often administered to patients with esophageal carcinoma in the belief that this will improve survival. However, its role in the management of esophageal carcinoma remains controversial. In this study we evaluated our experience with neoadjuvant chemoradiotherapy for the treatment of esophageal carcinoma.
Zhang, X, Watson, David Ian, Jamieson, Glyn G, Bessell, Justin, Devitt, Peter G   +4 more
openaire   +4 more sources